Dashboard
Manage Tickers

MIRM


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

mirum-pharma-to-share-multiple-presentations-featuring-data-from-livmarli-and-volixibat-clinical-programs-at-aaslds-the-liver-meeting-2025
Mirum Pharma To Share Multiple Presentatio...
11/07/2025 13:12:12

New data reinforce Mirum's commitment to advancing therapies and improving the lives of patients across diverse rare liver ...

cantor-fitzgerald-maintains-overweight-on-mirum-pharmaceuticals-raises-price-target-to-95
Cantor Fitzgerald Maintains Overweight on ...
11/05/2025 16:08:04

Cantor Fitzgerald analyst Josh Schimmer maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Overweight and raises the price...

citizens-maintains-market-outperform-on-mirum-pharmaceuticals-raises-price-target-to-95
Citizens Maintains Market Outperform on Mi...
11/05/2025 13:01:43

Citizens analyst Jonathan Wolleben maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Market Outperform and raises the pri...

what-analysts-are-saying-about-mirum-pharmaceuticals-stock
What Analysts Are Saying About Mirum Pharm...
11/05/2025 11:45:21

hc-wainwright--co-maintains-buy-on-mirum-pharmaceuticals-raises-price-target-to-81
HC Wainwright & Co. Maintains Buy on Mirum...
11/05/2025 11:32:45

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and raises t...

mirum-pharmaceuticals-raises-fy2025-sales-guidance-from-490000m-510000m-to-500000m-510000m-vs-505800m-est
Mirum Pharmaceuticals Raises FY2025 Sales ...
11/04/2025 21:03:12

Mirum Pharmaceuticals (NASDAQ:MIRM) raises FY2025 sales outlook from $490.000 million-$510.000 million to $500.000 million-$510...

mirum-pharmaceuticals-q3-eps-005-beats-014-estimate-sales-133010m-beat-130074m-estimate
Mirum Pharmaceuticals Q3 EPS $0.05 Beats $...
11/04/2025 21:02:49

Mirum Pharmaceuticals (NASDAQ:MIRM) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of...

earnings-scheduled-for-november-4-2025
Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

8-analysts-assess-mirum-pharmaceuticals-what-you-need-to-know
8 Analysts Assess Mirum Pharmaceuticals: W...
10/16/2025 20:00:37

morgan-stanley-maintains-overweight-on-mirum-pharmaceuticals-raises-price-target-to-81
Morgan Stanley Maintains Overweight on Mir...
10/16/2025 18:00:33

Morgan Stanley analyst Michael Ulz maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Overweight and raises the price targ...

this-riot-platforms-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Riot Platforms Analyst Begins Coverag...
09/24/2025 18:35:36

td-cowen-initiates-coverage-on-mirum-pharmaceuticals-with-buy-rating-announces-price-target-of-95
TD Cowen Initiates Coverage On Mirum Pharm...
09/24/2025 16:01:08

TD Cowen analyst Joseph Thome initiates coverage on Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy rating and announces Pric...

demystifying-mirum-pharmaceuticals-insights-from-6-analyst-reviews
Demystifying Mirum Pharmaceuticals: Insigh...
09/12/2025 13:01:47

jp-morgan-maintains-overweight-on-mirum-pharmaceuticals-raises-price-target-to-77
JP Morgan Maintains Overweight on Mirum Ph...
09/12/2025 11:16:31

JP Morgan analyst Jessica Fye maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Overweight and raises the price target fr...

mirum-pharmaceuticals-completes-enrollment-in-phase-2b-vistas-study-topline-data-expected-q2-2026
Mirum Pharmaceuticals Completes Enrollment...
09/08/2025 12:08:48

stifel-reinstates-buy-on-mirum-pharmaceuticals-announces-89-price-target
Stifel Reinstates Buy on Mirum Pharmaceuti...
08/11/2025 11:11:37

Stifel analyst Dae Gon Ha reinstates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and announces $89 price target.

deep-dive-into-mirum-pharmaceuticals-stock-analyst-perspectives-6-ratings
Deep Dive Into Mirum Pharmaceuticals Stock...
08/08/2025 18:02:12

evercore-isi-group-maintains-outperform-on-mirum-pharmaceuticals-raises-price-target-to-89
Evercore ISI Group Maintains Outperform on...
08/08/2025 12:36:21

Evercore ISI Group analyst Gavin Clark-Gartner maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Outperform and raises th...

jmp-securities-maintains-market-outperform-on-mirum-pharmaceuticals-raises-price-target-to-81
JMP Securities Maintains Market Outperform...
08/07/2025 13:36:12

JMP Securities analyst Jonathan Wolleben maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Market Outperform and raises t...

raymond-james-maintains-strong-buy-on-mirum-pharmaceuticals-raises-price-target-to-82
Raymond James Maintains Strong Buy on Miru...
08/07/2025 13:04:37

Raymond James analyst Steven Seedhouse maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Strong Buy and raises the price ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION